Hepatocellular carcinoma in Native South Asian Pakistani population; Trends, clinico-pathological characteristics & differences in viral marker negative & viral-hepatocellular carcinoma

被引:24
作者
Butt A.S. [1 ]
Hamid S. [1 ]
Wadalawala A.A. [1 ]
Ghufran M. [2 ,3 ]
Javed A.A. [3 ]
Farooq O. [3 ,4 ]
Ahmed B. [3 ,4 ]
Haq T.U. [3 ,5 ]
Jafri W. [1 ]
机构
[1] Section of Gastroenterology, Department of Medicine, Aga Khan University and Hospital, Karachi 74800, Stadium Road
[2] Department of Family Medicine, Aga Khan University, Karachi
[3] Aga Khan University, Karachi
[4] Department of Medicine, Aga Khan University, Karachi
[5] Department of Radiology, Aga Khan University, Karachi
关键词
Hepatitis B; Hepatitis C; Hepatocellular Carcinoma; Pakistan; Viral marker negative HCC; Viral-HCC;
D O I
10.1186/1756-0500-6-137
中图分类号
学科分类号
摘要
Background: HCC is the fifth most common cancer globally. Our study was conducted to (1)investigate the trends and clinico-pathological characteristics of Hepatocellular carcinoma among native South Asian patients in Pakistan, (2)to estimate the prevalence as well as the trends of viral marker negative HCC and (3) to compare the clinico-pathological, radiological characteristics, applicability of treatment at diagnosis and prognostic factors among patients with both viral marker negative and viral marker positive-HCC being consulted at Aga Khan University Hospital(AKUH), Karachi, Pakistan. Method. Patients ≥18 years, already diagnosed to have HCC and visiting AKUH during 1999-2009 were identified using ICD code 1550. The diagnosis of HCC was made in the presence of characteristic features of HCC on triple-phasic CT scan/MRI or with histological findings on biopsy. Results: 645 patients were enrolled. Of these 546(84.7%) were viral-HCC and 99(15.3%) were viral marker negative HCC. Among viral-HCC group underlying etiology of cirrhosis was HCV in 67.9%, HBV in 21.8% and concomitant HBV with HCV or HDV in 10.3% cases. Majority (62.8%) patients had advanced HCC. Larger tumor size (p < 0.001), shorter duration between diagnosis of cirrhosis and HCC (p 0.03), concomitant Diabetes Mellitus (p < 0.001) were found significant factors associated with viral marker negative HCC. Conclusion: The burden of hepatocellular carcinoma is rising among native South Asian Pakistani population and the viral marker negative HCC are not uncommon in our population. Viral marker negative HCC tend not to be under surveillance as compared to viral-HCC and are diagnosed mostly at advanced stage & when they became symptomatic. © 2013 Butt et al.; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 37 条
[1]  
Bruix J.S.M., Management of hepatocellular carcinoma: An Update, Hepatology, 0, 0, pp. 1-35, (2010)
[2]  
Raza S.A., Clifford G.M., Franceschi S., Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: A systematic review, British Journal of Cancer, 96, 7, pp. 1127-1134, (2007)
[3]  
Toyoda H., Kumada T., Kiriyama S., Sone Y., Tanikawa M., Hisanaga Y., Kanamori A., Yamaguchi A., Isogai M., Kaneoka Y., Washizu J., Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma, Journal of Gastroenterology and Hepatology, 23, 3, pp. 459-466, (2008)
[4]  
Liu C.J., Kao J.H., Hepatitis B virus-related hepatocellular carcinoma: Epidemiology and pathogenic role of viral factors, J Chin Med Assoc, 70, 4, pp. 141-145, (2007)
[5]  
Dohmen K., Shigematsu H., Irie K., Ishibashi H., Comparison of the Clinical Characteristics among Hepatocellular Carcinoma of Hepatitis B, Hepatitis C and Non-B Non-C Patients, Hepato-Gastroenterology, 50, 54, pp. 2022-2027, (2003)
[6]  
Noguchi K., Nakashima O., Nakashima Y., Shiota K., Nawata H., Kojiro M., Clinicopathologic study on hepatocellular carcinoma negative for hepatitis B surface antigen and antibody to hepatitis C virus, Int J Mol Med, 6, 6, pp. 661-665, (2000)
[7]  
Koike Y., Shiratori Y., Sato S., Obi S., Teratani T., Imamura M., Hamamura K., Imai Y., Yoshida H., Shiina S., Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesion, Hepatology, 32, 6, pp. 1216-1223, (2000)
[8]  
Wands J.R., Prevention of hepatocellular carcinoma, New England Journal of Medicine, 351, 15, pp. 1567-1570, (2004)
[9]  
Iizuka N., Oka M., Yamada-Okabe H., Hamada K., Nakayama H., Mori N., Tamesa T., Okada T., Takemoto N., Matoba K., Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray, Int J Oncol, 24, 3, pp. 565-574, (2004)
[10]  
Benvegnu L., Alberti A., Patterns of hepatocellular carcinoma development in hepatitis B virus and hepatitis C virus related cirrhosis, Antiviral Research, 52, 2, pp. 199-207, (2001)